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Pro-inflammatory signals provided by the microenvi-
ronment are critical to activate dendritic cells (DCs),
components of the innate immune system that shape
both innate and adaptive immunity. However, to pre-
vent inappropriate immune activation, mechanisms
must be in place to restrain DC activation to ensure
DCs are activated only once sufficient stimuli have
been received. Here, we report that DC activation
and immunogenicity are regulated by the transcrip-
tional repressor Polycomb group factor 6 (PCGF6).
Pcgf6 is rapidly downregulated upon stimulation,
and this downregulation is necessary to permit
full DC activation. Silencing PCGF6 expression
enhanced both spontaneous and stimulated DC
activation. We show that PCGF6 associates with
the H3K4me3 demethylase JARID1c, and together,
they negatively regulate H3K4me3 levels in DCs.
Our results identify two key regulators, PCGF6 and
JARID1c that temper DC activation and implicate
active transcriptional silencing via histone demethy-
lation as a previously unappreciated mechanism for
regulating DC activation and quiescence.
INTRODUCTION
Dendritic cells (DCs) play an essential role in host defense by
recognizing invading pathogens, initiating inflammation, and
stimulating the activation and differentiation of T cells, central
mediators of the adaptive immune response. Key to the capacity
of DCs to fulfill these functions is their ability to transition from a
resting or quiescent state to an active state. A major pathway for
DC activation is provided by pattern recognition receptorsCell Repo
This is an open access article under the CC BY-N(PRRs) that recognize molecular patterns from microbes
termed PAMPS/MAMPS (pathogen-associated molecular pat-
terns/microbe-associated molecular patterns) and self-mole-
cules termed DAMPS (damage-associated molecular patterns)
(Hammer andMa, 2013;Macagno et al., 2007;Mogensen, 2009).
Despite their diversity, all PRRs initiate signaling pathways that
lead to coordinated changes in cellular biology necessary for the
effector function of DCs, most of which are underpinned by
broad changes in gene expression (Hammer and Ma, 2013;
Johnson and Ohashi, 2013). DCs that have undergone activation
enhance their antigen-presentation capacity, increase the
expression of costimulatory molecules such as CD80 and
CD86, and produce many cytokines, chemokines, and lipid me-
diators that shape the inflammatory microenvironment (Sallusto
et al., 1995). While the pathways that promote transcriptional
activation downstream of inflammatory and PRR signals are
well described (Ma¨kela¨ et al., 2009; Mogensen, 2009; Yoshimoto
et al., 1997), less is known about negative regulators that counter
activation signals.
One way of reinforcing transcriptional states in immune cells is
through reversible, gene-specific, post-translational modifica-
tions of histones (Wen et al., 2008b). Methylation of lysine 4 of
histone 3 (H3K4) marks transcriptionally active and accessible
genes (Dong et al., 2012; Muramoto et al., 2010). In DCs and
macrophages, H3K4me3 has been reported to be important
for IL-12p40 production following Toll-like receptor (TLR) activa-
tion (Foster et al., 2007;Wen et al., 2008a; Yu et al., 2015). Mech-
anistically, H3K4me3 can facilitate transcription by promoting
the initiation and elongation of transcripts of H3K4me3-marked
genes (Benayoun et al., 2014; Lauberth et al., 2013; Ruthenburg
et al., 2007).
Polycomb group factor 6 (PCGF6) (also known as MBLR for
Mel18 and Bmi1-like RING finger protein) is a member of the Pol-
ycomb group (PcG) family of transcriptional repressors (Akasaka
et al., 2002; Lee et al., 2007; Sun et al., 2015; Yang et al., 2016;
Zdzieblo et al., 2014). PCGF6 has been identified in Polycombrts 16, 1829–1837, August 16, 2016 Crown Copyright ª 2016 1829
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Pcgf6 Expression Inversely Corre-
lates with Activation Phenotype
(A–E) Gene expression of Pcgf6 and Il12b in
DCs stimulated with the indicated activators
determined by qRT-PCR normalized to Hprt. Data
are shown for one representative experiment of
at least two to five independent experiments.
(A) DCs stimulated with LPS for the indicated
times.
(B) Splenic DCs sorted from mouse spleens acti-
vated ex vivo with 10 ng/ml LPS for 4 hr.
(C) DCs stimulated with the indicated activators for
2 hr.
(D) DCs stimulated with the rIFNb (1,000 U/ml) and/
or LPS for 18 hr.
(E) DCs activated with indicated doses of stimuli
for 18 hr.
LPS (lipopolysaccharide, 10 ng/ml); Zym
(Zymosan, 10 mg/ml); Curd (Curdlan, 50 mg/ml);
HKEB (heat-killed Escherichia coli B 107/ml);
HKSA (heat-killed Staphylococcus aureus 107/ml);
ZymD (Zymosan-depleted, 10 mg/ml); HDM (house
dust mite, 50 mg/ml). See also Figure S1.repressive complexes (PRC1) that have H3K9 methyltransferase
and those that have H3K4 demethylase activity (Gao et al., 2012;
Lee et al., 2007). PCGF6 has been reported to have a role in em-
bryonic stem cell differentiation andmale germ cell development
(Sun et al., 2015; Yang et al., 2014; Zdzieblo et al., 2014); how-
ever, a function for PCGF6 in the biological context of DCs or
any immune cell has not been reported.
Here, we show that PCFG6 is a negative regulator of DC acti-
vation and function and is integral tomaintaining DCquiescence.
Downregulation of PCGF6 expression accompanies, and is
necessary for, DC activation by pro-inflammatory stimuli. We
demonstrate that H3K4me3 levels in DCs are regulated both
by PCGF6 and the histone demethylase JARID1c and that
both proteins maintain a quiescent state. These findings identify
two important negative regulators of DC activation and function
and demonstrate that maintaining DC quiescence is an active
process involving transcriptional silencing mechanisms.
RESULTS
Pcgf6 Is Expressed in Quiescent DCs and
Downregulated following Activation
Pcgf6was identified as being downregulated by lipopolysaccha-
ride (LPS), a strong proinflammatory stimulant, in a previously
performed microarray-based comparison of gene expression1830 Cell Reports 16, 1829–1837, August 16, 2016in quiescent versus activated DCs (Kane
et al., 2004). Since Polycomb proteins
are broadly known to regulate cellular
gene expression programs in cells, we
hypothesized that PCGF6 may repress
gene expression at the steady state and
that its downregulation following DC acti-
vation may favor increased transcription
of the many genes that are coordinately
expressed during DC activation. Pcgf6expression was characterized in DCs and was found to be
rapidly downregulated as early as 2 hr post activation with
LPS, coinciding with the induction of the proinflammatory cyto-
kine Il12b (p40 subunit), and was maintained for up to 36 hr (Fig-
ure 1A). Importantly, Pcgf6 was downregulated to a similar
extent in splenic DCs and granulocyte-macrophage colony-
stimulating factor (GM-CSF)-derived DCs (Figure 1B).
To determine whether Pcgf6 downregulation was stimulant
dependent, the expression of Pcgf6 following exposure of DCs
to a variety of stimulants was determined. Pcgf6 expression
inversely correlatedwith the extent of DC activation asmeasured
by expression of CD80, CD86, and MHCII and induction of the
inflammatory cytokine Il12b (Figures 1C, 1D, and S1). DCs
activated by strong pro-inflammatory stimuli such as LPS,
Zymosan, Curdlan, and interferon-b (IFN-b) reduced the expres-
sion of Pcgf6 by 50%–90%, whereas weaker stimuli such as
HDM and ZymD induced downregulation of Pcgf6 expression
to a lesser extent (Figure 1C). DCs were stimulated with titrated
doses of select activators to determine whether the failure to
downregulate Pcgf6 was due to the dose and not the nature of
the stimulus. Decreases in Pcgf6 expression again correlated
with the extent of DC activation (Figure 1E). These findings
demonstrate that the transcriptional repressor Pcgf6 is downre-
gulated following DC stimulation and directly correlates with the
activation status of DCs.
PCGF6 Maintains DC Quiescence by Negatively
Regulating DC Activation
To test the hypothesis that the downregulation of PCGF6 per-
mits, or facilitates, DC activation we used retroviral-mediated
gene transfer to force continued expression of PCGF6 in DCs
during activation (Figure S2A) (Krawczyk et al., 2008). Forced
expression of PCGF6 resulted in decreased expression of
CD80, CD86 and MHCII at steady state and following LPS-stim-
ulation, which could not be rescued by increasing doses of stim-
uli (Figures S2B and S2C). DCs constitutively expressing PCGF6
also produced lower levels of proinflammatory cytokines,
including interleukin 6 (IL-6), tumor necrosis factor a (TNF-a),
and IL-12p40 (Figure 2A). Decreased production of IL-12p40
and IL-12p70 and expression of Il12b were also detected by
ELISA and qRT-PCR, respectively (Figure 2B). This defect was
not rescued by increasing the dose of LPS stimulation (Fig-
ure S2D). DCs derived from FLT3L-treated cultures overexpress-
ing PCGF6 also produced less IL-12p40 following LPS activation
(Figure S2E). Concomitant with DC activation is an increase in
glycolysis to support the bio-energetic requirements of DC acti-
vation (Everts et al., 2014; Krawczyk et al., 2010). Consistent with
a role for PCGF6 in suppressing DC activation, we found that
DCs constitutively expressing PCGF6 had lower extracellular
acidification rate (ECAR) (surrogate of glycolysis) following LPS
stimulation (Figure 2C).
Interestingly, DCs that constitutively expressed PCGF6 pro-
duced more of the anti-inflammatory IL-10 both at rest and
following LPS stimulation (Figures 2D and S2F). IL-10 antago-
nizes DC activation by suppressing the upregulation of activation
markers and cytokines upon maturation (Corinti et al., 2001).
However, neutralizing the IL-10R had no effect on PCGF6-medi-
ated suppression of activation (Figures 2E and S2G). Further-
more, rIL-10 could not preventPcgf6 downregulation (Figure 2F).
These results suggest that PCGF6 and IL-10 operate in indepen-
dent pathways to suppress DC activation.
To address the functional role of PCGF6 in DCs, the ability of
transduced DCs to stimulate ovalbumin (OVA)-specific CD4+
and CD8+ TCR transgenic T cells (OT-II and OT-I) was examined.
DCs with constitutive expression of PCGF6 were less efficient at
inducing CD4+ T cell activation, measured by CD44 and CD25
expression, proliferation, and Th1 differentiation (measured by
IFN-g production) (Figure 2G–2I). Likewise, DCs constitutively
expressing PCGF6 were poor stimulators of CD8+ T cell activa-
tion, proliferation and IFN-g production in CD8+ T cells (Figures
2J–2L).
In complementary experiments, PCGF6 expression was
silenced by expressing a small hairpin RNA (shRNA) targeting
PCGF6 (shPcgf6) (Figure S3A). DCs with reduced PCGF6
expression (shPcgf6) displayed increased levels of CD86 and
MHCII in the resting state and following stimulation with LPS
over a range of concentrations (Figures 3A and S3B). Likewise,
silencing PCGF6 resulted in increased levels of IL-12p40 pro-
duction both at rest and following activation (Figures 3B and
3C). A second hairpin targeting Pcgf6 yielded similar results (Fig-
ures S3C–S3E). DCs with reduced PCGF6 expression derived
from FLT3L-treated cultures displayed a phenotype similar to
GM-CSF-derived DCs (Figure S3F). Both resting and LPS-acti-
vated DCs with reduced PCGF6 expression induced greater an-tigen-specific CD4+ and CD8+ T cell activation, as determined by
CD44 and CD25 expression, proliferation, and IFN-g production
(Figures 3D–3I). These results indicate that PCGF6 expression is
necessary for the maintenance of the resting state of DCs and
that decreasing PCGF6 expression, even in resting DCs, is suffi-
cient to stimulate stronger T cell responses.
Gene-Specific Regulation of Chromatin Accessibility
and H3K4me3 Levels by PCGF6
Polycomb proteins are broadly known to regulate gene expres-
sion programs in cells, often through the regulation of histone
modifications that influence chromatin structure and/or tran-
scription (Schuettengruber et al., 2007). To examine changes
in chromatin accessibility in the presence or absence of
PCGF6, we used an assay for transposase-accessible chro-
matin (ATAC) to examine specific genes important for DC activa-
tion. ATAC libraries were generated from DCs transduced with
eitherPcgf6 cDNA or shPcgf6. The accessibility of the promoters
of Ciita, H2-Ab1 (MHCII, IAb), Il12a, Il12b, and Actb was exam-
ined using high-throughput sequencing data (Figures 4A and
4B) and validated by qRT-PCRon an independent set of samples
(Figure S4). We observed decreased ATAC-qPCR enrichment
relative to input at the promoters of Ciita and Il12a in DCs
overexpressing PCGF6 (Figure S4), corresponding to reduced
accessibility at these loci. An overall trend to decreased signal in-
tensity by ATAC-sequencing (ATAC-seq) and relative enrich-
ment by ATAC-qPCR was observed in PCGF6-overexpressing
cells at the promoters of Ciita, H2-Ab1, Il12a, and Il12b (Figures
4A and S4). Conversely, there was a trend toward increased
signal intensity by ATAC-seq and relative enrichment by ATAC-
qPCR observed at these promoters upon depletion of PCGF6
(Figure 4B).
Since PCGF6 has been found in complexes with H3K4 deme-
thylase activity (Lee et al., 2007), we examined whether PCGF6
could regulate H3K4me3 levels in DCs. We first examined
whether changes in Pcgf6 expression correlated with changes
in H3K4methylation in DCs using flow cytometry.We specifically
gated on LPS-stimulated cells that were either IL-12p40hiMHCIIhi
or IL-12p40lowMHCIIlow and compared the fluorescence inten-
sity (Figure 4C). Consistent with its role as an activating epige-
netic signature, we observed a positive correlation between
the extent of H3K4me3 and the degree of cellular activation.
Ectopic PCGF6 expression resulted in a decrease in H3K4me3
in both resting and LPS-stimulated DCs (Figure 4D), indicating
that PCGF6 promotes H3K4 demethylation in DCs.
We examined H3K4me3 levels at the promoters of Ciita,
H2-Ab1, Il12a, and Il12b using a-H3K4me3 chromatin immuno-
precipitation (ChIP) qPCR (Figure 4E). We found a significant
decrease in the enrichment of H3K4me3 at these promoters
upon ectopic expression of PCGF6 and an increase in
H3K4me3 enrichment with Pcgf6 knockdown (Figure 4E). Levels
of H3K4me3 were not significantly changed at the Actb
promoter.
Maintenance of DC Quiescence by PCGF6 Is Dependent
on JARID1c
PCGF6 was shown to be associated with and promote the his-
tone demethylase activity of JARID1d, a histone demethylaseCell Reports 16, 1829–1837, August 16, 2016 1831
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Figure 2. PCGF6 Negatively Regulates DC Activation
(A) DCs transduced with MSCV-based retrovirus (control) or virus expressing Pcgf6 cDNA (PCGF6) were stimulated for 6 hr and stained intracellularly for the
indicated cytokines. Plots show cells that are transduced (gated on hCD8 reporter). Frequency of gated events and the geometric mean fluorescence intensity
(geoMFI) of the gated cells (bottom right) are indicated.
(B) Secreted IL-12p40 and IL-12p70 and expression of Il12b following 18-hr stimulation with LPS.
(C) Real-time ECAR (mpH/min) of transduced DCs during LPS stimulation (100 ng/ml) measured by a Seahorse bioanalyzer. Error bar represents SEM.
(D) IL-10 secretion and expression levels were determined as in (B).
(E) IL-12p70 production by transduced DCs stimulated with LPS ± rIL10 (20 ng/ml) or anti-CD210 (10 mg/ml) for 18 hr.
(F) Pcgf6 and Il12b expression in DCs stimulated with LPS ± rIL-10.
(legend continued on next page)
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Figure 3. PCGF6 Regulates Both the Resting and Activated States of DCs
(A and B) MHCII, CD86 and IL-12p40 expression in DCs transduced with an shRNA targeting PCGF6 (shPcgf6) or empty vector (control) at rest and following
stimulation with LPS for 6 hr. Plots show transduced (hCD8+) cells.
(C) Secreted levels of IL-12p40 following 18 hr of LPS stimulation.
(D–I) CD4+ and CD8+ T cell co-culture experiments were performed as in Figure 2. Data are representative of three to five independent experiments.
See also Figure S3.that acts on H3K4me2 and H3K4me3 (Lee et al., 2007). Because
our studies were performed with DCs from female mice that do
not express the Y-linked JARID1d, we focused our attention on(G–L) Sorted transduced DCs were pulsed with ovalbumin protein ± LPS for 6 hr. F
T cells that were labeled or not with proliferation dye.
(G, H, J, and K) 3–4 days after co-culture, the extent of T cell activation and pro
dilution, respectively. Shown are CD4+CD44+ cells (H) and CD8+ cells (K).
(I and L) 4–5 days after co-culture, T cells were stimulated for 4 hr with PMA and
Unless otherwise indicated, error bars represent error calculated by SD of tw
experiments. See also Figure S2.the X-linked homolog, JARID1c, another H3K4 demethylase
(Outchkourov et al., 2013). PCGF6 and JARID1c were found
to interact in DCs by co-immunoprecipitation (Figure 5A).ollowing stimulation, DCs were co-cultured with CD4+ OTII T cells or CD8+ OTI
liferation was measured by CD25 and CD44 expression and proliferation dye
ionomycin and stained intracellularly for IFN-g.
o or three replicates. Data are representative of at least three independent
Cell Reports 16, 1829–1837, August 16, 2016 1833
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Figure 4. PCGF6 Suppresses H3K4me3
Levels in Resting and Activated DCs
(A and B) ATAC-seq of transduced resting DCs.
Screenshot from a genome browser of peaks
generated by ATAC-seq observed in proximity to
the indicated genes. Peaks are a pileup of
sequence alignments over the specified regions
resulting from the ATAC reaction. The number in
the top left of each panel represents the scale of
the signal intensity. Called peaks are indicated by
the shaded rectangles, where darkness of the
rectangle represents relative intensity of the signal.
(C) DCs activated with LPS for 6 hr were stained
intracellularly for MHCII, IL-12p40 (left), and
H3K4me3 levels (right) and analyzed by flow
cytometry. Inset values are the geoMFI of the
adjacent histogram.
(D) H3K4me3 levels determined by flow cytometry
in resting and LPS-stimulated DCs. GeoMFI is
quantified on the right panel.
(C and D) Error bars represent SD of triplicate
samples.
(E) ChIP of H3K4me3 in transduced DCs followed
by qPCR of the promoters of indicated genes.
ChIPs were performed on three biological repli-
cates. Error bars indicate the SEM of pooled qPCR
values from three independent ChIP experiments.
*p < 0.05, **p < 0.005. See also Figure S4.Unlike PCGF6, Jarid1c expression increased slightly (2-fold)
in response to LPS stimulation (Figure S5A). DCs expressing
JARID1c-specific shRNA (shJarid1c) had increased levels of
H3K4me3 (Figures 5B and S5B), consistent with the role of
JARID1c as a histone demethylase in DCs.
Similar to cells expressing Pcgf6-specific shRNAs, expressing
shJarid1c in DCs led to increased CD80, MHCII, and Il-12p40
levels both at rest and in response to LPS stimulation (Figures
5C and 5D). To examine whether JARID1c activity was needed
for PCGF6-mediated suppression, we co-expressed PCGF6
and shJarid1c (Figure 5E). In the absence of JARID1c, PCGF6
was only partially able to suppress the expression of costimula-
tory molecules and IL-12p40 production (Figure 5F). Further-
more, PCGF6 could not suppressH2-Ab1 andCiitamRNA levels1834 Cell Reports 16, 1829–1837, August 16, 2016to the same extent in the absence of JAR-
ID1c (Figures 5G and S5C). Together,
these data demonstrate that PCGF6 and
JARID1c work in concert to negatively
regulate the expression of key genes
involved in DC activation and that
JARID1c is required in part for PCGF6-
mediated suppression.
DISCUSSION
Controlled activation of DCs is necessary
to prevent the inappropriate induction of
inflammation and activation of T cell re-
sponses, resulting in immunopathology
and/or autoimmunity. Thus, it is important
that the induction of the proinflammatoryphenotype be restrained until sufficient, and appropriate, stimuli
have been received. The maintenance of DC quiescence and the
transition to activation are dynamic processes that require the
coordinated induction of many genes necessary for their effector
function. Here, we have identified two transcriptional repressors,
PCGF6 and JARID1c, which cooperate to suppress the expres-
sion of genes that are associated with DC activation. Our work
contributes to emerging evidence that maintaining the resting
state in DCs is an active process involving negative regulators
of transcription (Huang et al., 2012; Johnson and Ohashi,
2013). Our data also reveal that expression of PCGF6 must
be downregulated to permit full activation of genes necessary
for the acquisition of effector function of DCs in response to
proinflammatory stimuli.
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Figure 5. PCGF6 Negatively Regulates DC
Activation in Part through JARID1c
(A) Immunoprecipitation (IP) performed on lysates
from transduced DCs immunoblotted with anti-
JARID1c.
(B) DCs transduced with a control vector or shJar-
id1c were activated with LPS for 6 hr. H3K4me3
levels were measured by flow cytometry.
(C and D) Transduced DCs treated as in (B) were
assayed for surface marker expression and intra-
cellular cytokine production (gated on hCD8+ cells).
(E–G) DCs were transduced on days 1 and 2 of
culture with either a relevant control vector (CV) or
one expressing shJarid1c or PCGF6.
(E) Expression of Pcgf6 and Jarid1c in double-
transduced DCs measured by qRT-PCR and
normalized to Hprt.
(F) Expression of MHCII, CD86, and intracellular
IL-12p40 on human CD8+ cells.
(G) Expression ofH2-Ab1mRNA in transduced DCs.
Shown are data from one representative experiment
out of three different experiments.
See also Figure S4.DCs are poised to respond rapidly to their environment,
and one mechanism to facilitate rapid responses could be tran-
scriptional readiness, wherein the locus is primed and awaiting
the arrival of activated transcription factors. Based on the
ATAC experiments performed, the promoters of genes important
for DC activation and function are relatively ‘‘open’’ at rest, in line
with the need to have them immediately transcribed following
PRR signaling. We found that expression levels of PCGF6
affected the ‘‘openness’’ of these promoters. While there are
many chromatin modifications that can affect chromatin struc-
ture, we focused on H3K4me3 given the association of
H3K4me3 with transcriptional activation and the published
report that PCFG6 can interact with the H3K4 demethylase
JARID1d (Lee et al., 2007). We found that H3K4me3 levels are
increased in highly activated cells (MHCIIhip40hi) compared to
immature cells and that PCGF6 expression decreased the global
signal of H3K4me3.We specifically analyzed promoters of genes
important for DC activation and found that PCGF6 expression
decreases the level of H3K4me3 at these promoters. Mechanis-
tically, we demonstrate that PCGF6 can associate with JARID1c
and that the suppressive activity of PCGF6 in DCs is, in part,
dependent on JARID1c. PCGF6 can also promote the transcrip-
tion of genes such as IL-10, but the net effect of PCGF6-medi-
ated regulation of gene expression is to dampen DC activation
and promote a more quiescent state.Cell ReActive maintenance of the quiescent
state is important for the fine-tuning of DC
responses to a range of stimuli that have
the potential to activate DCs. Here, we pro-
vide evidence that the extent to which
these activating signals translate into tran-
scriptional activation is tempered by nega-
tive regulators of transcription such as
PCGF6 and JARID1c. PCGF6 and JARID1c
antagonizemRNA expression by regulatingH3K4me3 levels and in doing so promote a quiescent pheno-
type. In the absence of JARID1c and PCGF6, DCs are more
active at rest, and at least for PCGF6, stimulate enhanced
T cell responses. Therefore maintenance of the quiescent state
via transcriptional repression in DCs has important conse-
quences for the induction of both innate and adaptive immune
responses.
Our findings demonstrate that PCGF6 and JARID1c regulate
DC activation and function by actively suppressing H3K4me3
levels. These data support emerging evidence that constitutive
inhibitory mechanisms are in place to regulate DC quiescence
and temper activation. In the case of PCGF6, the expression of
these factors must be downregulated to permit DC activation
and subsequent triggering of adaptive immunity.EXPERIMENTAL PROCEDURES
Mice and Reagents
C57BL/6 (Charles River Laboratories). OTII transgenic (Jackson 004194) and
OTI (Jackson 003831) mice were maintained under specific-pathogen-free
conditions at McGill University. All procedures were carried out in accordance
with guidelines of the Canadian Council on Animal Care, as approved by the
Animal Care Committee of McGill University. DC activators included LPS
(Escherichia coli serotype 0111:B4) (Sigma-Aldrich), HDM (low endotoxin,
Greer laboratories), Zymosan and Zymosan depleted of TLR ligands (Invivo-
gen). Cytokines included GM-CSF, IL-10, and IFN-b (Peprotech). A CD4+ports 16, 1829–1837, August 16, 2016 1835
and CD8+ T cell negative selection kit (STEMCELL Technologies), Pan-DC
enrichment kit, and phycoerythrin (PE)-positive selection kit (Miltenyi Biotec)
were used. Antibodies are listed in Table S1. ELISA Ready-set-go kits: IL-
12/23 p40, IL-12 p70, and IL-10 (eBioscience). Media reagents were RPMI
(Corning, Thermo Fisher Scientific), Iscove’s modified Dulbecco’s media, fetal
calf serum (FCS), L-glutamine and penicillin/streptomycin (Wisent), and non-
essential amino acids (Gibco, Invitrogen).
Bone-Marrow Derived Dendritic Cells Culture and Transduction
Bone marrow cells were cultured and stimulated as described (Krawczyk
et al., 2008). For intracellular staining bone-marrow derived dendritic cells
(BMDCs) were incubated with brefeldin for 2 hr before the end of stimulation
then fixed and permeabilized (eBioscience kit). Flt3L-derived BMDCs were
generated as above using media containing 20% conditioned supernatants
from a B16 cell line expressing FLT3L in place of GM-CSF. BMDC cultures
were transduced as described using retrovirus produced in 293Ts trans-
fected with either mouse stem cell virus (MSCV) or LMP-based (Krawczyk
et al., 2008; Paddison et al., 2004) retroviral vectors using Lipofectamine
2000.
Gene Expression
RNA was extracted (Trizol) and cDNA was generated to perform SYBR-based
qRT-PCR (For primers, see Table S2). Relative fold change was calculated us-
ing the DDCq method. The SD of triplicate samples was combined with the SD
of the reference gene by error propagation. The range of fold change was then
calculated by the formula 2(DDCq ± s), and the SD of the range in fold change
represents the error bars indicated in the qPCR bar graphs.
Splenic DC Preparation and Ex Vivo Activation
Spleens from C57BL/6 mice were treated with collagenase and DNase for
20 min at 37C and homogenized through a 70-mm filter, and red blood cells
were lysed with ammonium chloride solution (150 mM NH4Cl, 10 mM Tris,
[pH 7]). DCs were isolated from total splenocytes by MACS pan-DC enrich-
ment according to the manufacturer’s protocol.
Seahorse Assay
Seahorse Extracellular Flux Analyzer was used to measure ECAR (mpH/min)
following LPS stimulation. Briefly, sorted DCs were plated in six replicates in
seahorse media freshly supplemented with 10% FCS, 2 mM L-Glutamine,
25 mM Glucose and 300 nM NaOH (pH adjusted to 7.4). LPS was injected
directly by the Seahorse (final concentration, 100 ng/ml) measurements of
ECAR were recorded every 5 min.
DC-T Cell Co-culture
23 104 sorted DCs were stimulated or not with LPS (10 ng/ml) and whole OVA
protein (2 mg/ml) per well in 96-well plates. 6 hr following stimulation, 2 3 105
sorted CD4+ T cells from OTII mice were added (1:10 ratio). On day 3 or 4,
T cells were examined for proliferation (pre-labeled with CFSE or e450
Proliferation Dye) and expression of cell-surface activation markers. To detect
cytokine production by intracellular staining, cells were stimulated for 4 hr with
phorbol 12-myristate 13-acetate (PMA) (50 ng/ml) and ionomycin (500 ng/ml).
For CD8+ co-cultures, 1 3 104 sorted DCs were stimulated or not with LPS
(0.5 ng/ml) and whole OVA protein (1 mg/mL) in 96-well plates and co-cultured
and analyzed as described above.
H3K4me3 Staining and Chromatin Immunoprecipitation
To detect intracellular H3K4me3, cells were fixed with 4% PFA for 20 min at
room temperature and washed and permeabilized with 100% methanol at
4C for at least 30 min. Cells were then washed and stained at 4C. ChIP
was performed essentially as described in (Memari et al., 2015) with modifica-
tions detailed in Supplemental Experimental Procedures. Briefly, cells were
cross-linked and lysed to obtain nuclei. Nuclei were lysed with sonication
and chromatin was used for overnight immunoprecipitation (IP) at 4C. Immu-
noprecipitated DNA was used as a template for qPCR specific to the promoter
region of the indicated genes. Statistical significance was determined by an
unpaired t test.1836 Cell Reports 16, 1829–1837, August 16, 2016ATAC-Seq
ATAC-seq libraries from transduced DCs were sorted by fluorescence-acti-
vated cell sorting (FACS) for high hCD8, CD11c+ cells and were prepared as
previously described (Buenrostro et al., 2013) using 5 3 104 cells per sample
and 50 ng DNA per input. Library preparation was achieved with DNA Library
Preparation Kit (Illumina), and fragments were size-selected using Caliper
LabChIP system (PerkinElmer). Reads were aligned to the Mouse genome
(mm10) using Burrows-Wheeler Alignment tool (BWA) (Li and Durbin, 2009).
Duplicate reads were marked and removed using Picard (https://github.
com/broadinstitute/picard). For comparisons, the larger dataset was down-
sampled to match the size of smaller dataset using Picard (https://github.
com/broadinstitute/picard). Peaks were called using MACS2.0 (https://
github.com/taoliu/MACS/) (Zhang et al., 2008) For ATAC-qPCR, ATAC
libraries were prepared from three independent biological replicates as
described above and used in real-time qPCR using the same primers listed
for ChIP-qPCR. The fold enrichment relative to input was normalized to a
negative control region.
Co-immunoprecipitation
Cell lysates from transduced DCs were prepared using RIPA lysis buffer
(150 mM NaCl, 5 mM EDTA, 50 mM Tris [pH 5], 10% NP-40, 0.5% sodium
deoxycholate, and 0.1% SDS) with protease inhibitor cocktail tablets
(Roche). The lysates (1 mg) were cleared then incubated with beads pre-
coated with either anti-FLAG M2 or normal mouse IgG for 2 hr. The beads
were washed, and the proteins were eluted by boiling and processed for
western blot using anti-JARID1c. 10% input (100 mg) was loaded as a
control.
Statistical Analysis
Statistical analysis was performed using Prism 6.0b software and/or Microsoft
Excel. Statistical significance was determined by unpaired t tests and indi-
cated (n.s., not significant; *p < 0.05; **p < 0.05). Error bars represent either
SD or SEM as described in the figure legends.
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